Industry Insights with Bas Trietsch and STEMCELL Technologies
Update: 2024-12-03
Description
In this interview, Drs. Bas Trietsch from MIMETAS and Jenna Moccia from STEMCELL Technologies explore the use of stem cell-based models in drug discovery. They discuss how regulatory milestones underscore the growing acceptance of these models, prompting scientists to seek out clinically predictive tools such as organoids and organ-on-a-chip systems.
You can learn more about the importance of human-based 3D model systems, their impact on drug discovery, and the future outlook of this technology in the full interview with Jenna and Bas here.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
